Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer
Authors
Keywords
-
Journal
Cancer Cell International
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-30
DOI
10.1186/s12935-020-01184-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways
- (2018) You Dong Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer
- (2017) A C West et al. ONCOGENE
- Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease
- (2016) Rona Yaeger et al. GASTROENTEROLOGY
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Damage-associated molecular patterns in cancer: a double-edged sword
- (2016) C Hernandez et al. ONCOGENE
- Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-κB Mediated Inflammation in Colon Cancer Patients
- (2016) Abdelhabib Semlali et al. PLoS One
- Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma
- (2016) Katy Mastorci et al. PLoS One
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TLR2andTLR4polymorphisms influence mRNA and protein expression in colorectal cancer
- (2015) Marcela Alcântara Proença WORLD JOURNAL OF GASTROENTEROLOGY
- Upregulation of TLRs and IL-6 as a Marker in Human Colorectal Cancer
- (2014) Chien-Chang Lu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A cell-intrinsic role for TLR2–MYD88 in intestinal and breast epithelia and oncogenesis
- (2014) Ferenc A. Scheeren et al. NATURE CELL BIOLOGY
- TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
- (2013) Yu Liu et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Tumor fibroblast–derived epiregulin promotes growth of colitis-associated neoplasms through ERK
- (2013) Clemens Neufert et al. JOURNAL OF CLINICAL INVESTIGATION
- Toll-Like Receptor Polymorphisms, Inflammatory and Infectious Diseases, Allergies, and Cancer
- (2013) Andrei E. Medvedev JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis
- (2013) C L Kennedy et al. ONCOGENE
- Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers
- (2011) Alexandru V. Olaru et al. INFLAMMATORY BOWEL DISEASES
- Animal Models of Colitis-Associated Carcinogenesis
- (2011) Manasa Kanneganti et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas
- (2010) Marco Gerling et al. ANNALS OF SURGERY
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
- (2009) B. B. Aggarwal et al. CLINICAL CANCER RESEARCH
- Tlr2 is critical for diet-induced metabolic syndrome in a murine model
- (2009) Ryan W. Himes et al. FASEB JOURNAL
- Colitis-associated cancer: the role of T cells in tumor development
- (2009) Maximilian J. Waldner et al. Seminars in Immunopathology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started